An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus

By Dewulf J.   Laevens H.   Koenen F.   Mintiens K.   de Kruif A.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 86-91

Elsevier

Access to resources Recommend Favorite

Candidate peptide vaccine induced protection against classical swine fever virus

By Dong X.-N.   Wei K.   Liu Z.-Q.   Chen Y.-H.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 167-173

Elsevier

Access to resources Recommend Favorite

Influence of maternal antibodies on efficacy of a subunit vaccine: transmission of classical swine fever virus between pigs vaccinated at 2 weeks of age

By Klinkenberg D.   Moormann R.J.M.   de Smit A.J.   Bouma A.   de Jong M.C.M.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 3005-3013

Elsevier

Access to resources Recommend Favorite

Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever

By Hammond J.M.   McCoy R.J.   Jansen E.S.   Morrissy C.J.   Hodgson A.L.M.   Johnson M.A.  

Vaccine, Vol. 18, Iss. 11, 2000-01 ,pp. : 1040-1050

Elsevier

Access to resources Recommend Favorite

An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV)

By van Rijn P.A.   van Gennip H.G.P.   Moormann R.J.M.  

Vaccine, Vol. 17, Iss. 5, 1999-02 ,pp. : 433-440

Elsevier

Access to resources Recommend Favorite